Feyruz Rassool, Ph.D. associate professor, Department of Radiation, is senior author on a paper with Sallmyr A, Fan J, Datta K, Kim KT, Grosu D, Shapiro P, and Small D, “Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML” Blood. 2008 Mar 15;111(6):3173-82. Epub 2008 Jan 11.
Ming
T. Tan, Ph.D. professor, Department of Epidemiology and Preventive
Medicine,, authored an article “Conditional Power in Clinical Trial Monitoring.”
Wiley Encyclopedia of Clinical Trials, D'Agostino R, ed., Wiley-Interscience
2008.
Feyruz Rassool, Ph.D., associate professor, Department of Radiation, has an invited talk at the American Association for Cancer Research (AACR) on April 13 in a session entitled: A Paradigm Rift in Myelodysplastic Syndromes: New Insights Range from Bench to Bedside. The title of her presentation is: “Reactive oxygen species (ROS), DNA Damage and Repair Errors: A Model for Genomic Instability in Myelodysplastic Syndromes.”
Ronald B. Gartenhaus, M.D., associate professor, Department of Medicine, received notice of a new three-year Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award, "Translational Control and Breast Cancer Development" for a total of $325,500. The start date is July 1, 2008.
Martin
J. Edelman, M.D., professor, Department of Medicine and director
of Medical Thoracic Oncology, received notice of a new, two-year grant from
the International Association for the Study of Lung Cancer to supervise M. Naomi
Horiba, M.D., for a project entitled "Myeloid derived suppressor cells
in non small cell lung cancer: Influence of tumor bulk and COX-2" for a
total of $80,000. The start date is July 1, 2008.
Geoffrey
Girnun, Ph.D., assistant professor, Department of Biochemistry
and Molecular Biology, received notice of a new three-year Susan G. Komen Career
Catalyst Award, “Bioenergetic Control of Breast Cancer Growth by the Transcriptional
Coactivator PGC1alpha” for a total of $450,000. The start date is May
1, 2008.
Edward
Sausville, M.D., Ph.D., Professor, Department of Medicine, received
notice of a new Maryland Affiliate of Susan G. Komen for the Cure “Improving
Support and Accrual to NCI-Sponsored Breast Cancer Clinical Trials” for
$75,000. The start date is April 1, 2008.